SOURCES SOUGHT
65 -- Over The Counter (OTC) Rapid Antigen Test Manufacturing
- Notice Date
- 7/19/2023 12:43:51 PM
- Notice Type
- Sources Sought
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- ASPR/DAAPPO/ORM HQ Washington DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- ASPR072023
- Response Due
- 7/26/2023 9:00:00 AM
- Archive Date
- 08/10/2023
- Point of Contact
- Mary Masamo
- E-Mail Address
-
IBMSC-Submissions@hhs.gov
(IBMSC-Submissions@hhs.gov)
- Description
- This is a Request for Information (RFI) only.�� As set forth in FAR 15.201(e), the purpose of an RFI is to obtain market information. This RFI requests information about current domestic manufacturing capacities for Over the Counter (OTC) rapid antigen SARS-CoV-2 tests within U.S. facilities. This RFI is not a request for competitive proposals: therefore, responses to this notice are not considered offers and cannot be accepted by the Government to form a binding contract. Companies that respond will not be paid for submitting information. The Government intends to utilize information gathered from this RFI for planning and market research purposes.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/3936134e84a6437b97bd80fc6939cf87/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06756126-F 20230721/230719230052 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |